Sachs Associates

We are pleased to share another great presentations from the 11th Annual HealthTech Investment Forum #Sachs_HTIF Leo Smit, CEO, Hy2Care® BV, during the Sachs Autumn Life Sciences Week, shares the story of Hy2Care's unique CartRevive hydrogel implant, developed to enable optimal cartilage repair in the knee. Through this therapy, Hy2Care® aims to improve surgical outcomes and reduce the need for repeat surgeries. Hy2Care revolutionizes cartilage repair with CartRevive® hydrogel implant of joint-matching composition, enabling the body to heal itself. It was founded by a patient, now in the clinical stage, ready to disrupt orthopedics. Hy2Care® is a ‘spin-off company’ of the Tech Med Centre at the University of Twente (NL) and was founded in 2014. Of the original founders, Prof. Dr. Marcel Karperien and Dr. Sanne Both, continue to be active in the company.  Hy2Care’s launching product, the CartRevive® hydrogel implant for cartilage repair in the knee, is in the last phase of a clinical investigation in the Netherlands for European market approval. The first clinical results show significantly superior results compared to existing standard-of-care therapies. With the FDA Breakthrough Design Designation received, Hy2Care is currently preparing for IDE submission and intends to start initialization of its US trial in 2025. Hy2Care’s innovative platform centers on the CartRevive™ hydrogel implant's in-situ formation. Upon application to a cartilage defect, two naturally derived polymers, Dextran and Hyaluronic acid-conjugates, gelate within a minute. Simultaneously, the implant attaches itself to the surrounding cartilage and bone, providing a strongly fixated resorbable scaffold that degrades over time. The joint-mimicking composition forms a natural environment for the patient's cells to quickly populate the implant and initiate the natural repair of the cartilage. The unique therapy provides natural tissue healing, comparable to best-in-class cell-technology, at a fraction of the cost. Hy2Care is currently raising €9M series B round to complete preparations for the US trial, obtain CE mark and initiate first commercial treatments in Europe. To view click here: https://lnkd.in/dgxtGKRK #HealthTech #DigitalHealth #MedTech #HealthTechInnovation #BigData #AI #HealthTechForum #PharmaTechnology #MedicalDevices #HealthcareTechnology #HealthTechInvestment #SALSW

We are pleased to share seed session from the 24th Annual Biotech in Europe Forum. Rising Stars – Biotech Seed Companies Session from the 24th Annual Biotech in Europe Forum #Sachs_BEF. Moderated by: Dragan Grabulovski, Founder & CEO, grabulovski consulting services GmbH Tamas Schweighoffer, Co-Founding Partner, Forty51 Ventures Presenters: 1. Modiblast Pharma GmbH - Helga Schmetzer, CEO/CSO 2. PROSION Therapeutics GmbH - Slim Chiha, Co-Founder & CEO 3. Akribion Therapeutics GmbH - Lukas Linnig, CFA, CEO 4. ABYOLO AG - Sönke Steinert, Co-Founder 5. AIPTO TechBio GmbH - Xian Zhang, CEO 6. Curaxon AG - Nikhil Gokhale, Co-Founder 7. THERAtRAME S.A. - Jonathan Ward, CEO 8. NatIgGs GmbH - Karthikeyan (Karthik) B., Founder & CEO 9. Cantoni Therapeutics BV - Annegret Van der Aa, CEO 10. Roca Therapeutics - Maeva Dufies, CSO 11. FluoSphera SA - Gregory Segala, CSO 12. Ariya Bio c/o ETH Zürich - Jan Nelis, Co-Founder & Project Lead To view now, please click here: https://lnkd.in/dyDbMSAc #BigPharma #Dealmakers #PharmaIndustry #BiotechInEuropeForum #LifeSciences #Biotech #BioPharma #Partnering #Investment #Startups #Oncology #Neurology #Genomics #Immunotherapy #CNS #Autoimmune #Cardiovascular #BiotechIndustry #BioTechInvestment #Innovation #InvestmentForum #BiotechConference #EuropeanBiotech #SachsAutumnLifeSciencesWeek #SALSW

Early stage investments can be difficult. That's why we gathered professionals at the top of their field to discuss how to make a decision you can trust. We are pleased to share the Early-Stage Ventures Panel: Picking Winners from the 24th Annual Biotech in Europe Forum #Sachs_BEF. Co-Chaired by: Marie Schroeder, Vice President, Novo Holdings A/S Shelley Margetson, Managing Partner, V-Bio Ventures BV Panellists: Edward Van Wezel, Managing Partner, BGV (BioGeneration Ventures) Laurent Jacqueroud, BD & Investment Director, Cumulus Oncology Michael Altorfer, CEO, Swiss Biotech Association Michael R Huebner, Director Early Innovation Partnering, Johnson & Johnson Innovation LLC Stephan Emmerth, Director, BaseLaunch To view, please click here: https://lnkd.in/d_3BMDbC #BiotechInvestment #VentureCapital #EarlyStageInvesting #StartupSuccess #BiotechStartups #Innovation #Sachs_BEF #SALSW

We are pleased to share Renée Aguiar-Lucander's story on the impressive billion-dollar exit. Fireside Discussion: "How I Took a European Biotech to a Billion-Dollar Exit" with Renee Aguiar-Lucander, CEO, Calliditas Therapeutics AB , moderated by Victoria English, Co-Founder & Editor, MedNous (Evernow Publishing Ltd) from the 24th Annual Biotech in Europe Forum #Sachs_BEF. To view now, please click here: https://lnkd.in/d33xAKir #BigPharma #Dealmakers #PharmaIndustry #BiotechInEuropeForum #LifeSciences #Biotech #BioPharma #Partnering #Investment #Startups #Oncology #Neurology #Genomics #Immunotherapy #CNS #Autoimmune #Cardiovascular #BiotechIndustry #BioTechInvestment #Innovation #InvestmentForum #BiotechConference #EuropeanBiotech #SachsAutumnLifeSciencesWeek #SALSW

We are pleased to share another great session from the 24th Annual Biotech in Europe Forum. Neurological Disorders Panel: Rapid Advances with New Targets & Modalities from the 24th Annual #Sachs_BEF. Chaired by: Keld Flintholm Jørgensen, SVP & CBO, H. Lundbeck A/S Panellists: Antti Vuolanto, CEO, Herantis Pharma Plc. Carlos Buesa, Founder & CEO, Oryzon Genomics SA Federico Bolognani, MD, PhD, Chief Medical Officer, IAMA Therapeutics S.r.l. Lynn A Durham, Founder & CEO, STALICLA SA Rupert H., CEO, Avata Biosciences To view now, please click here: https://lnkd.in/dv8r3yfP #Neuroscience #NeurologyAdvances #MedicalResearch #Biotech #GeneTherapy #PersonalizedMedicine #SALSW

We are please to share another great session from the 11th Annual HealthTech Investment Forum. MedTech & Device Markets Panel: Innovation & Capital from the 11th Annual #Sachs_HTIF. Co-Chaired by: Beat Merz, Managing Director, New Harbor Venture Partners, LLC Eli Yered, CFO, Sanara Ventures Panellists: Edouard GOBITZ, Managing Partner, Asklepios Advisors Laurent Choppe, Managing Partner, Cukierman & Co. Life Sciences Leo Smit, CEO, Hy2Care® BV Marco Wendel, Managing Director, Medical Valley EMN e. V. Remi Spagnol, Investment Director, Supernova Invest To view now, please click here: https://lnkd.in/dpkDYj7B #MedTechInnovation #MedicalDevices #HealthTechInvesting #BiomedicalEngineering #DigitalHealth #HealthcareSolutions #SALSW

We are pleased to share this great workshop by Laura Lane from the 24th Annual Biotech in Europe Forum. Workshop: “Collaborations that Push Boundaries: Partnering with Lilly” by Laura A. Lane, VP, Lilly Ventures – Europe Head External Innovation, Eli Lilly and Company from the 24th Annual #Sachs_BEF. To view now, please click here: https://lnkd.in/dnWdSbi5 #BigPharma #Dealmakers #PharmaIndustry #BiotechInEuropeForum #LifeSciences #Biotech #BioPharma #Partnering #Investment #Startups #Oncology #Neurology #Genomics #Immunotherapy #CNS #Autoimmune #Cardiovascular #BiotechIndustry #BioTechInvestment #Innovation #InvestmentForum #BiotechConference #EuropeanBiotech #SachsAutumnLifeSciencesWeek #SALSW

We are pleased to share another great session from the 24th Annual Biotech in Europe Forum. AI Transforming BioPharma Panel: Beyond the Hype from the 24th Annual Biotech in Europe Forum #Sachs_BEF. Chaired by: Sarah Holland, President of Swiss HLG & CBO, Cureteq AG - a Partex Company Panellists: Frank Grams, Chief Commercial Officer, Partex N.V. Katharina Kreymborg, SVP, Curie.Bio Patrick Schwab, Senior Director, AI & Machine Learning, GSK Ricardo Gaminha Pacheco, Strategic Partnering, BD&L Director, Insilico Medicine To view, please click here: https://lnkd.in/dS_tnC6E #ArtificialIntelligence #Biopharma #DrugDiscovery #BiotechInnovation #PharmaTech #AI #LifeSciences #SALSW

"AI" became a buzzword no one can ignore anymore. Ruthy shared her insights how AI can be used in Healthcare to ensure the best patient outcomes and help medical professionals ensure the best of care. Keynote Speech: “Harnessing AI in Healthcare” by Ruthy Kaidar, Managing Director Healthcare, EMEA, Microsoft Corporation from the 11th Annual HealthTech Investment Forum #Sachs_HTIF. To view, please click here: https://lnkd.in/dHuqqKYm #DataDrivenHealth #PatientCare #HealthTech #DigitalHealth #MedicalDiagnostics #AIinHealthcare #SALSW

It is important to stay on top of innovation in HealthTech. We are happy to share this outstanding session guiding the audience through the complexities of Big Data & AI. Digital Pharma & Therapeutics Innovation Panel: Leveraging Big Data & AI from the 11th Annual HealthTech Investment Forum #Sachs_HTIF. Co-Chaired by: Dr. Cem Baydar, Chief Investment Officer, Eczacıbaşı Topluluğu Pharmaceutical and Industrial Investment Co. Tanja Dowe, Managing Director, Angelini Ventures S.p.A. Panellists: Angela Zubel, CDO, Debiopharm International SA Bracy Fertig PhD, VP Strategy & Corporate Development, Caresyntax Corp. Christian Hein, Executive Advisor & Board Member, QuantHealth Tamara Gerbert, Founder, VP of Strategy & Director of Neuroscience, Brightmind.AI Ulrich Muehlner, Founder & Managing Director, @GrowthCube Partners LLC To view now, please click here: https://lnkd.in/dJvup9JK #DigitalHealth #PharmaInnovation #BigData #ArtificialIntelligence #HealthTech #MedTech #SALSW